Perhaps the term “better” should not be defined by business metrics at all—but instead by the innovation’s health impacts ...

The Trump administration has proposed capping Medicaid state directed payments (SDPs) at 100 percent of Medicare rates in Medicaid expansion states and 110 percent of Medicare rat ...

In its current configuration, Food Is Medicine operates as a drain, not a fountain. Money flows into communities to pay for food and services, and grants are paid to support short-term projects, but ...

Amidst uncertainties around Older Americans Act reauthorization and turmoil at the Administration for Community Living, the nation’s aging network and advocates are trying to sustain the ...

California cannot control whether mifepristone will remain available at the national level. But it can control whether Medi-Cal managed care plans can connect patients to providers and verified ...

The CMS actuaries are—understandably and reasonably—cautious. But recent developments indicate that changes in technology and policy may alter health care delivery and spending—and consequently our ...

Foreign reference pricing frameworks often differ from the way the US has historically valued medical innovation. A more ...

Congress should require the FDA to make DSCSA traceability data accessible and interpretable not only by regulatory agencies ...

The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of ...

Exhibit 1 National health expenditures (NHE) and personal health care (PHC) expenditures, aggregate and per capita amounts, share of gross domestic product (GDP), and annual growth, selected calendar ...

Rather than impose one-size-fits-all solutions, federal and state policy makers should craft Medicaid payment policies that ...

Nasal naloxone remains expensive relative to the cost of the underlying drug and continues to strain budgets of public health ...